Effects of liposome-mediated gene transfer of VEGF in ischemic rat gracilis muscle.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 11288154.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of the current study was to determine the effects of vascular endothelial growth factor (VEGF) on muscle flap survival and vascularity in a rat gracilis ischemia-reperfusion model. A total of 12 adult male Wistar rats were divided into two groups (n = 6). The experimental group received the plasmid encoding VEGF(165) cDNA plus lipofectamine (cationic liposome) injected directly to the gracilis muscle following 4 h of ischemia. The control group received lipofectamine only. The viability and vascularity of the flaps were evaluated after 7 days of reperfusion. The data demonstrated that the VEGF plasmid- and lipofectamine-treated muscle flaps had significantly greater total survival and capillary count 7 days after reperfusion compared with the flaps treated only with lipofectamine. These results indicate that VEGF exerts a protective effect on ischemic skeletal muscle flaps.
Medical subject headings
- Cation Exchange Resins
- Endothelial Growth Factors
- Gene Transfer Techniques
- Genetic Therapy
- Ischemia
- Lipids
- Lymphokines
- Muscle, Skeletal